Understanding riluzole and its role in ALS care in New Zealand Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that devastates muscle strength and mobility. Riluzole is one of the few disease-modifying therapies available for ALS and is often discussed as a first-line option in early care plans. In Aotearoa New Zealand, healthcare providers…